[1]史贻芳.普米克令舒联合氨溴索治疗新生儿肺炎的临床疗效观察[J].医学信息,2018,31(04):132-133.[doi:10.3969/j.issn.1006-1959.2018.04.047]
　SHI Yi-fang.Clinical Effect of Pulmicort Combined with Ambroxol in the Treatment of Neonatal Pneumonia[J].Journal of Medical Information,2018,31(04):132-133.[doi:10.3969/j.issn.1006-1959.2018.04.047]
点击复制

普米克令舒联合氨溴索治疗新生儿肺炎的临床疗效观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年04期
页码:
132-133
栏目:
药物与临床
出版日期:
2018-02-15

文章信息/Info

Title:
Clinical Effect of Pulmicort Combined with Ambroxol in the Treatment of Neonatal Pneumonia
文章编号:
1006-1959（2018）04-0132-02
作者:
史贻芳
沈阳市儿童医院新生儿科，辽宁 沈阳 110023
Author(s):
SHI Yi-fang
Department of Neonatric,Shenyang Children's Hospital, Shenyang 110023,Liaoning,China
关键词:
普米克令舒; 氨溴索; 新生儿肺炎
Keywords:
Key words：Pulmicort; Ambroxol; Neonatal pneumonia
分类号:
R722.1
DOI:
10.3969/j.issn.1006-1959.2018.04.047
文献标志码:
A
摘要:
目的 观察普米令舒联合氨溴索治疗新生儿肺炎的临床疗效，评价其临床应用价值。方法 选取我院2016年3月~2017年4月收治的114例肺炎新生儿，随机分为研究组与常规组，各57例。所有患儿均实施营养补充、预防感染、吸氧措施等基础治疗，在此前提下常规组患儿采用普米克令舒治疗，研究组在此基础上加用氨溴索，观察两组患儿的治疗效果、住院时间、咳嗽消失时间、肺啰音消失时间、治疗有效率及家长满意度。结果 研究组治疗总有效率优于常规组（96.48% vs 82.46%），组间比较差异有统计学意义（P＜0.05）；研究组患儿的咳嗽消失时间、肺啰音消失时间、退热时间、吸氧时间及住院时间均优于常规组，差异有统计学意义（P＜0.05）；研究组患儿家长治疗满意度高于常规组（98.25% vs 87.72%），差异有统计学意义（P＜0.05）。结论 采用普米令舒联合氨溴索治疗新生儿肺炎，临床疗效显著，患儿症状消退快，家长满意度高，值得临床应用推广。
Abstract:
Abstract：Objective To observe the clinical effect of Pulmicort combined with Ambroxol in the treatment of neonatal pneumonia,and to make an evaluation of its clinical application value.Methods From March 2016 to April 2017,114 newborns with pneumonia were randomly divided into study group and routine group,57 cases of each group.All children were given nutritional supplement,infection prevention,oxygen inhalation measures and other basic treatment,the routine group was treated with Pulmicort and the study group was treated with ambroxol on the above basis.The therapeutic effects,length of hospital stay,disappearance of cough,disappearance of pulmonary rales,treatment efficiency and parents' satisfaction were observed in both groups.Results The total effective rate of the study group was better than that of the routine group(96.48%vs82.46%),there was significant difference between the two groups(P< 0.05),and the time of cough disappearance,lung rale disappearance,antipyretic time,oxygen absorption time and hospitalization time in the study group were better than those in the routine group,the difference was statistically significant(P<0.05),the satisfaction of the parents in the study group was higher than that of the routine group(98.25%vs87.72%),and the difference was statistically significant (P<0.05).Conclusion The clinical efficacy of Pulmicort combined with ambroxol in the treatment of neonatal pneumonia is significant. The symptoms of children are rapidly subsided and their parents' satisfaction is high,which is worthy of clinical application and promotion.

参考文献/References:

[1]杨红霞.普米克令舒联合氨溴索雾化治疗新生儿肺炎的疗效观察[J].河南医学研究,2015(9):127-128.
[2]黄圣元,石少连,.普米克令舒联合氨溴索治疗新生儿肺炎的效果观察[J].临床医学工程,2016,23(3):355-356.
[3]潘娜,崔亚琦.氨溴索与普米克令舒联合雾化治疗新生儿肺炎疗效及安全性评价[J].中国实用医药,2016,11(26):265-266.

相似文献/References:

[1]刘成丽.氨溴索在哮喘性支气管炎治疗中的应用效果及安全性评价[J].医学信息,2018,31(05):138.[doi:10.3969/j.issn.1006-1959.2018.05.049]
　LIU Cheng-li.Efficacy and Safety Evaluation of Ambroxol in the Treatment of Asthmatic Bronchitis[J].Journal of Medical Information,2018,31(04):138.[doi:10.3969/j.issn.1006-1959.2018.05.049]
[2]罗玉霞.舒适护理在布地奈德联合氨溴索雾化吸入治疗 慢阻肺急性发作患者的效果分析[J].医学信息,2018,31(12):179.[doi:10.3969/j.issn.1006-1959.2018.12.058]
　LUO Yu-xia.Analysis of the Effect of Comfortable Nursing in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients with Aerosolized Inhalation of Budesonide and Ambroxol[J].Journal of Medical Information,2018,31(04):179.[doi:10.3969/j.issn.1006-1959.2018.12.058]
[3]陈孝辉.哌拉西林钠他唑巴坦钠联合氨溴索治疗慢性阻塞性肺疾病的临床效果[J].医学信息,2022,35(13):97.[doi:10.3969/j.issn.1006-1959.2022.13.021]
　CHEN Xiao-hui.Clinical Effect of Piperacillin Sodium and Tazobactam Sodium Combined with Ambroxol in the Treatment of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2022,35(04):97.[doi:10.3969/j.issn.1006-1959.2022.13.021]
[4]聂优华,刘育斌.孟鲁司特联合普米克令舒吸入剂治疗小儿哮喘的疗效及对患儿炎性因子的影响[J].医学信息,2022,35(20):130.[doi:10.3969/j.issn.1006-1959.2022.20.035]
　NIE You-hua,LIU Yu-bin.Effect of of Montelukast Combined with Pulmicort Respules Inhalation in Treatment of Pediatric Asthma and its Influence on Inflammatory Factors[J].Journal of Medical Information,2022,35(04):130.[doi:10.3969/j.issn.1006-1959.2022.20.035]
[5]刘斌先.布地奈德、沙丁胺醇雾化吸入联合氨溴索注射液治疗小儿支气管肺炎的效果及对WBC、CRP的影响[J].医学信息,2024,37(02):136.[doi:10.3969/j.issn.1006-1959.2024.02.027]
　LIU Bin-xian.Clinical Effect of Budesonide and Salbutamol Aerosol Inhalation Combined with Ambroxol Injection in the Treatment of Bronchial Pneumonia in Children and its Effect on WBC and CRP[J].Journal of Medical Information,2024,37(04):136.[doi:10.3969/j.issn.1006-1959.2024.02.027]

更新日期/Last Update: 2018-02-15